Krystal Biotech, Inc. (KRYS) Most Active Options

The 25 most actively traded Krystal Biotech, Inc. (KRYS) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$367.61
52-week range
$134.88 – $375.95
ATM IV (30d)
38.9%
IV rank
50 / 100
Moderate
Expected move
±$19.82 (±5.4%)
Put/call OI
0.70
Call-heavy
Max pain
$310
↓ 15.7% below close
Next earnings
Aug 5, 2026

Most Active KRYS Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
KRYS $330 put Aug 21, 2026 42d $11.37 50.6% 68 -0.24 10 150 37.7× avg
KRYS $380 call Aug 21, 2026 42d $16.43 49.7% 89 0.45 92 150 24.6× avg
KRYS $420 call Jul 17, 2026 7d $0.25 77.8% 65 0.11 1 146 2.5× avg
KRYS $350 call Jul 17, 2026 7d $15.90 38.2% 69 0.81 82 48 2.6× avg
KRYS $320 call Jul 17, 2026 7d $44.10 0.0% 0 1.00 811 13 0.7× avg
KRYS $370 call Jul 17, 2026 7d $6.20 38.9% 7 0.43 65 13 3.3× avg
KRYS $470 put Nov 20, 2026 133d $117.20 51.8% 84 -0.73 0 13 6.0× avg
KRYS $340 call Jul 17, 2026 7d $20.30 36.9% 67 0.93 19 10 0.5× avg
KRYS $430 call Jul 17, 2026 7d $0.10 91.7% 89 0.11 2 6 0.1× avg
KRYS $360 call Nov 20, 2026 133d $48.00 51.5% 72 0.60 16 4 3.3× avg
KRYS $360 call Jul 17, 2026 7d $8.90 39.2% 0 0.63 24 3 0.4× avg
KRYS $320 put Aug 21, 2026 42d $8.10 50.5% 68 -0.19 16 2 0.5× avg
KRYS $380 call Jul 17, 2026 7d $2.37 38.0% 0 0.25 55 2 0.5× avg
KRYS $290 put Aug 21, 2026 42d $2.80 52.1% 40 -0.08 6 1 2.0× avg
KRYS $300 put Aug 21, 2026 42d $4.10 50.1% 32 -0.10 45 1 2.0× avg
KRYS $450 call Jul 17, 2026 7d $2.00 81.9% 0 0.04 0 1 1.0× avg
KRYS $350 put Jul 17, 2026 7d $2.85 45.7% 100 -0.23 7 1 0.3× avg
KRYS $360 put Aug 21, 2026 42d $24.77 51.5% 71 -0.42 6 1 0.5× avg
KRYS $480 put Aug 21, 2026 42d $112.00 56.8% 52 -0.90 0 1 13.0× avg
KRYS $330 call Nov 20, 2026 133d $63.00 52.3% 70 0.70 9 1 1.4× avg
KRYS $160 put Jun 17, 2027 342d $4.50 61.4% 26 -0.04 0 1 20.6× avg
KRYS $250 call Feb 19, 2027 224d $129.80 59.2% 84 0.86 0 1 2.9× avg
KRYS $310 call Feb 19, 2027 224d $88.09 56.8% 96 0.74 51 1 3.2× avg
KRYS $350 put Aug 21, 2026 42d $19.92 50.7% 67 -0.36 2 1 0.5× avg
KRYS $450 put Jul 17, 2026 7d $81.50 88.3% 88 -0.95 0 1 8.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active KRYS contract today is the $330 put expiring in 42 days, with 150 contracts traded. Calls dominate the most-active list (14 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on KRYS for free

Build multi-leg KRYS strategies, visualize payoffs, and scan the full US options universe with OptiView.

KRYS Options FAQ

Which KRYS option contract is most active today?

The most traded KRYS contract is the $330 put expiring Aug 21, 2026, with 150 contracts traded as of Jul 10, 2026.

How does OptiView rank the most active KRYS options?

The table lists the 25 KRYS contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.